Skip to content

Transplant Rejection

Transplant rejection is a condition in which the immune system responds against a transplanted organ. Treatment focuses on reducing this immune response. Sirolimus is an ingredient used for transplant rejection.

Medicine used to treat Transplant Rejection

Rapamycin

Sirolimus

1mg

Rapamycin contains sirolimus in a tablet used for transplant rejection. It is supplied in one strength and several pack sizes. You can compare the price per tablet across options.

FromUS$3.96/ tabletView

Key points

  • Rapamycin contains the active ingredient sirolimus.
  • The strength available is 1mg.
  • Rapamycin is supplied as a tablet.

What transplant rejection is

Rejection happens when the immune system reacts to a donated organ. The reaction is directed at the transplanted tissue. It can affect how well the organ works. Care teams monitor for rejection after surgery.

Signs to watch for

The signs can differ according to the organ involved. Some changes are found through blood tests or scans before a person notices them. Others may cause symptoms that prompt a call to the transplant team. Reporting changes early helps the team decide what to do.

Treatment

Treatment is aimed at controlling the immune response. Rapamycin (sirolimus) 1mg tablets are used for transplant rejection. Rapamycin contains sirolimus; the sirolimus ingredient entry gives more detail. For the condition, see transplant rejection. Autoimmune support is another section to review. Pharmacy partners in India ship to Malaysia in discreet packaging.

When to seek advice

Speak to your transplant team if you have questions about your medicine, notice new symptoms, or are worried about rejection. They can advise on monitoring and next steps. Do not stop or change a medicine without their guidance.

Further reading

Last updated